Ingen internetforbindelse — viser den gemte version af siden.

NewAmsterdam Phar…

USUSD
← Til screeneren

NewAmsterdam Pharma Company N.V. Ordinary Shares (US:NAMS) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 1. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om virksomheden

Websted
ir.newamsterdampharma.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
NARRDEN, Netherlands
Administrerende direktør
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Ansatte
100
Udestående aktier
119.54 mio. pr. 2026-08-03
Free float
81.5 mio.
Markedsværdi
2.89 mia. USD
Insidere
0.9%
Institutionelle investorer
106.61%
Branche (SIC)
Pharmaceutical Preparations
Beskrivelse

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksNAMSUSD23.2 -3.97%almindelige aktier
US USA StocksNAMSWUSD12.65 +0.00%

Kurs over 3 måneder

US:NAMS · USD
stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Ingen udbyttebetalinger fundet (tjekket 06.10.2026). Virksomheden udbetaler sandsynligvis ikke udbytte.

annonce

Største ejere

EjerAndelAktierRapportdato
Frazier Life Sciences Ma…15.13%18.09 mio.2026-06-30
Capital World Investors10.23%12.23 mio.2026-06-30
FMR, LLC8.65%10.34 mio.2026-06-30
RA Capital Management, L…7.99%9.55 mio.2026-06-30
SmallCap World Fund Inc7.75%9.27 mio.2026-06-30
FCPM III Services B.V.7.1%8.49 mio.2026-06-30
Deerfield Management Com…3.57%4.26 mio.2026-06-30
Viking Global Investors,…3.52%4.2 mio.2026-06-30
Bain Capital Life Scienc…3.18%3.81 mio.2026-06-30
Maverick Capital Ltd.2.73%3.27 mio.2026-06-30
Duquesne Family Office L…2.57%3.07 mio.2026-06-30
Fidelity Contrafund1.95%2.33 mio.2026-07-31
Fidelity Rutland Square…1.87%2.24 mio.2026-07-31
DAVIDSON MICHAEL H (Chie…≈0.9%1.08 mio.2026-09-14
New Economy Fund0.8%957 4772026-06-30
T. Rowe Price Health Sci…0.76%912 5002026-06-30
Fidelity Select Portfoli…0.71%847 6002026-07-31
-Capital Group U.S. Smal…0.51%608 6602026-05-31
iShares Trust-iShares Bi…0.5%603 1242026-08-31
Prudential Sector Funds,…0.45%534 1022026-05-31
American Century Mutual…0.44%524 2412026-07-31
SOMAIYA MAYUR IAN (Chief…≈0.05%58 3822026-01-21
MARINO MICHAEL F III (Of…≈0.05%55 0002025-05-30
KLING DOUGLAS F (Chief O…≈0.04%44 0002025-07-16
JONES WILLIAM A JR (Offi…≈0.04%43 0002025-01-07
KOOIJ LOUISE FREDERIKA (…≈0.02%24 3532026-07-20
AUDET JULIETTE BERANGERE…≈0.01%15 1042025-01-07
FORGROWTH NAP B.V. (Bene…——2024-12-30
KASTELEIN JOHANNES JACOB…——2026-08-24
TOPPER JAMES N (Director…——2025-09-15

Hændelser hos tilsynet

DatoTilsynsmyndighedBegivenhedDetaljer
2026-10-02SECінсайдерська подачаФорма 4
2026-09-29SECпоточний звітФорма 8-K